PMA device
Capsure Epicardial Pacing Lead
Medtronic, Inc. · Permanent Defibrillator Electrodes (NVY, Class III) · First FDA decision Feb 28, 2013, newest Dec 24, 2013Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Capsure Epicardial Pacing"
MAUDE reports
12
Brand "Capsure Epicardial Pacing", since 2015
PubMed studies
0
Mentioning "Capsure Epicardial Pacing"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Capsure Epicardial Pacing Lead
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CAPSURE EPICARDIAL PACING LEADPMA supplement
P950024-S048 · Decided Dec 24, 2013 · 258 days after receipt · Normal 180 Day Track No User Fee
Device type: Permanent defibrillator electrodes (NVY) · Cardiology
- CAPSURE EPICARDIAL PACING LEADPMA supplement
P950024-S038 · Decided Feb 28, 2013 · 465 days after receipt · Normal 180 Day Track
Device type: Permanent defibrillator electrodes (NVY) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Capsure Epicardial Pacing", any status and sponsor, newest update first.
No registered device study names "Capsure Epicardial Pacing".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Capsure Epicardial Pacing", and for the whole product code for context.
This brand
12 reports: 4 malfunction, 7 injury, 1 death
Whole product code NVY
107,231 reports: 45,328 malfunction, 59,528 injury, 2,263 death
Newest reports for this brand
- CAPSURE EPICARDIAL PACING LEADMalfunction
MW5175782 · Received Sep 8, 2025 · Event dated Aug 28, 2025
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Signal Artifact/Noise
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW5174656 · Received Aug 15, 2025 · Event dated Jul 24, 2025
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: False Alarm; Ambient Noise Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW5170543 · Received May 19, 2025 · Event dated Apr 7, 2025
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Erythema; Unspecified Infection; Swelling/ Edema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Capsure Epicardial Pacing"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NVY.
- Sprint Quattro Secure MRI SureScan Model 6947M leadMedtronic, Inc. · PMA 2022
- Attain Starfix LeadMedtronic, Inc. · PMA 2014
- Capsurefix Novus MRI Surescan Lead Model 5076Medtronic, Inc. · PMA 2016
- Passive Plus, Isoflex S&p, and Isoflex Optim LeadsAbbott Medical · PMA 2015
- OmniaSecure MRI SureScan Lead Model 3930MMedtronic, Inc. · PMA 2026
- Medtronic(R) Transvene Lead SystemMedtronic, Inc. · PMA 2020
- Selectsecure LeadMedtronic Cardiac Rhythm Disease Management · PMA 2016
- Medtronic 4195 Attain Starfix Model 4195 LV LeadMedtronic, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.